您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (1): 85-88.doi: 10.6040/j.issn.1671-7554.0.2013.332

• 临床医学 • 上一篇    下一篇

慢性乙型肝炎疾病进展中瞬时弹性波检测的意义及其影响因素

刘伟1,丁艾昆2,李程2,单容3,王昌源1,2   

  1. 1. 山东大学医学院,济南 250012; 2. 济南市传染病医院七科, 济南 250021;
    3. 济南市传染病医院超声诊断科, 济南 250021
  • 收稿日期:2013-05-21 出版日期:2014-01-10 发布日期:2014-01-10
  • 通讯作者: 王昌源,Email: wangcy5440@163.com

Significance and influential factors of Fibroscan detection  in the progress of patients with chronic hepatitis B disease

LIU Wei1, DING Ai-kun2, LI Cheng2, SHAN Rong3, WANG Chang-yuan1,2   

  1. 1. School of Medicine, Shandong University, Jinan 250012, China;
    2. Seventh Department of Jinan Infectious Disease Hospital, Jinan 250021, China;
    3. Department of Ultrasound, Jinan Infectious Disease Hospital, Jinan 250021, China
  • Received:2013-05-21 Online:2014-01-10 Published:2014-01-10

摘要:

目的  探讨瞬时弹性波检测(Fibroscan,FS)对慢性乙型肝炎患者疾病进展的评价作用及影响因素。方法  收集660例FS检测的慢性乙型肝炎患者临床资料和其中96进行肝组织活检的病理结果,分析各临床指标对FS值(硬度值)的影响。根据肝脏病理纤维化分期进行分类,绘制不同纤维化分期FS值的受试者工作特征曲线(ROC),计算曲线下面积(AUC)。结果  不同性别、年龄、PLT、PTA、ALT、TBIL、ALB、门脉内径和脾脏厚度水平的FS值有差异(P<0.05)。多元线性逐步回归分析显示,ALT、PTA、ALB、脾脏厚度、门静脉内径、PLT、TBIL与FS值相关,其对FS值的影响依次减弱。肝纤维化轻度(S1)18例、中度(S2)39例、重度(S3)12例和肝硬化(S4)27例的AUC分别为0.724、0.832、0.836和0.798,诊断的界值分别为9.8、10.5、12.3和14.8kPa。结论   FS与肝脏病理纤维化分期符合率高,是评估慢性乙型肝炎疾病进展有价值的无创检查方法。

关键词: 肝脏硬度, 慢性乙型肝炎, 瞬时弹性波检测, 肝纤维化, 肝硬化

Abstract:

Objective  To explore the evaluation effect and analyze the influential factors of Fibroscan (FS) detection in the progress of patients with chronic hepatitis B disease. Methods  Six hundred and sixty patients with chronic hepatitis B disease were detected with Fibroscan and their clinical data were collected, and 96 of them had liver biopsy Results  . Influences of various clinical indicators on FS values were analyzed. The 96 cases were grouped based on their fibrosis stage in biopsy, the receiver-operating characteristic curves (ROC) of FS values were drawn and the areas under the curve (AUC) were calculated. Results  Multiple clinical indexes, such as age, gender, PLT, PTA, ALT, TBIL, the inner diameter of portal vein and thickness of spleen were associated with FS value, and their differences between different levels had statistical significance(P<0.05). Multiple linear stepwise regression analysis showed that ALT, PTA, thickness of spleen, the inner diameter of portal vein, PLT and TBIL were correlated with FS value. According to the absolute value of the standard regression coefficient, the influence of these indicators on FS value decreased gradually. The AUCs of FS detection for 18 cases of mild (S1), 39 cases of moderate (S2), 12 cases of severe (S3) degree liver fibrosis and 27 cases of cirrhosis (S4) were 0.724, 0.832, 0.836 and 0.798, respectively, and the cut-off values for diagnosis of various degree of fibrosis and cirrhosis were 9.8, 10.5, 12.3 and 14.8 kPa, respectively. Conclusion  Fibroscan detection has a high coincidence rate with liver pathological fibrosis stage. It is a very effective and noninvasive examination in assessing disease progression of patients with chronic hepatitis B disease.

Key words: Liver stiffness;Chronic hepatitis B, Fibroscan, Liver fibrosis, Liver cirrhosis

[1] 王韶卿 刘毅慧 付婷婷 成金勇 刘强. 肝癌31磷磁共振波谱数据的分类[J]. 山东大学学报(医学版), 2209, 47(6): 42-46.
[2] 刘秋霞,王磊,刘峰,曲云东,叶茜,钱钰,张媛,张立新. 慢性HBV感染患者长期服用阿德福韦酯与肾性低磷血症的相关因素[J]. 山东大学学报(医学版), 2017, 55(7): 73-78.
[3] 展凤霞,丁娟,马蓓蕾,王谦. 雌二醇对Th1细胞极化与肝纤维化形成的影响[J]. 山东大学学报(医学版), 2016, 54(8): 64-68.
[4] 张琨,张孝国,崔杏杏,陈士俊. 慢性HBV感染者外周血单个核细胞凋亡相关因子的表达及其与乙肝慢性化的关系[J]. 山东大学学报(医学版), 2016, 54(7): 38-42.
[5] 钱钰,曲云东,王子瑜,刘峰,叶茜,王磊. 影响慢性乙型肝炎病毒感染患者肾功能的危险因素[J]. 山东大学学报(医学版), 2016, 54(1): 29-32.
[6] 刘彩峰, 汪明明, 李新立, 崔速南. 托伐普坦治疗肝硬化顽固性腹水并低钠血症的疗效[J]. 山东大学学报(医学版), 2016, 54(1): 33-37.
[7] 黄旻. 肝硬化上消化道出血的内科治疗方法探讨[J]. 山东大学学报(医学版), 2014, 52(S2): 24-24.
[8] 吴斌, 何文涛, 程云峰, 章以法, 吴东刚. 肝硬化患者血清高密度脂蛋白胆固醇检测的临床意义[J]. 山东大学学报(医学版), 2014, 52(S2): 19-19.
[9] 刘士锦. 肝硬化合并上消化道出血患者的观察与护理[J]. 山东大学学报(医学版), 2014, 52(S2): 130-131.
[10] 欧珠美朵, 嘎松卓嘎, 旦增. 白细胞介素-10基因多态性与西藏地区慢性乙型肝炎的相关性研究[J]. 山东大学学报(医学版), 2014, 52(S1): 9-9.
[11] 欧阳兵, 彭忠田, 王培. 大麻素受体1与FAK在血吸虫肝纤维化小鼠肝组织中的表达[J]. 山东大学学报(医学版), 2014, 52(9): 11-14.
[12] 刘同燕1,张龙跃2,李月荣3,孙经利2,韩增禄3,李志荃2,张立新1,王磊1. 干扰素α与阿德福韦酯治疗HBeAg阳性慢性乙型肝炎前瞻性队列观察[J]. 山东大学学报(医学版), 2014, 52(6): 72-78.
[13] 吴善彬,许洪伟,刘慧,李宾. 血管内血管旁联合注射硬化剂治疗食管静脉曲张出血[J]. 山东大学学报(医学版), 2014, 52(6): 85-89.
[14] 潘家超1,2,张乐1,2, 徐琳琳3,单晓宇2,杜文军2,陈士俊2. 黑素瘤缺乏因子2诱导的固有免疫在慢性乙型肝炎发病机制中的作用[J]. 山东大学学报(医学版), 2014, 52(4): 74-79.
[15] 李继业, 王薇, 潘润华, 阿斯楞, 廖彩仙. 肝脏FibroScan测定和功能评分与肝硬化病理分级的相关性[J]. 山东大学学报(医学版), 2014, 52(12): 83-88.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!